NEW YORK, March 5 – Proteologics, a proteomics startup in Rehovot, Israel, has obtained $14 million in financing from venture capital firms, the company said Monday.

Concord Ventures, also based in Israel, led the financing with $9 million, with U.S .Venture Capital firm ABS Ventures and the Giza Fund, one of Israel's largest venture capital groups, supplying the remainder.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.